ASHPOfficial

This Isn’t Exactly How I Pictured it Happening: Leadership During Unusual Times

A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Community Pharmacy: Training Future Leaders

In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

MCM 2021 COVID-19 Coverage: A Pharmacy Leader’s Toolkit for Adjusting Operations During a Pandemic

During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Big Data, Big Bias: Understanding Underlying Biases in AI and CDS

As technology advances and you continue to automate your pharmacy, have you ever asked yourself if your software solutions are the right fit for the patient population you serve? This podcast seeks to open your eyes to potential biases that could be present in your use of artificial intelligence, machine learning, and clinical decision support. Join our mixed clinical and industrial panel of experts as we discuss challenges associated with bias and potential mitigating strategies to overcome. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacogenomic Testing in Children: Which Tests and What Comes After Testing?

In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts from St. Judes Children’s Research Hospital and Boston Children’s Hospital share how their organizations have integrated pharmacogenomics into their programs including pre-emptive testing, identifying drug-gene pairs, integration into the electronic medical records and addressing the familial implications of pharmacogenomic testing.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Practical Implementation of Remote Continuous Glucose Monitoring in Hospitalized Patients with Diabetes

In this podcast, Dr. Matt Baker, Dr. Megan Musselman, Rachel Rodgers, and Dr. Richard Hellman, discuss their cross-disciplinary effort to implement continuous glucose monitoring in the inpatient setting with host and AJHP Editor in Chief, Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Incorporating Wellness into the PharmD Curriculum

Maintaining wellness throughout the pursuit of a Doctorate of Pharmacy degree is challenging. Students must have open conversations about the difficulties of staying well so that we can normalize feeling unwell. In this episode, students from across the country share their experiences and tips to encourage others to maintain healthy lives and relationships throughout their pharmacy school careers. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

CMS Takes on DIR Fees

This podcast discusses the proposed rule change that CMS has made to Medicare Advantage and Part D around DIR Fees. Nick Gentile and Jillanne Schulte go through why this rule change was made, how it will effect ASHP members, and what ASHP members can do.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Advantage: Pharmacist Education on Immunotherapy: An Investment into the Patient as a Team Member in irAE Management

This discussion highlights the importance of pharmacist education of patients on immunotherapy, and barriers that may prevent patients from becoming active participants in the identification and management of irAEs.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Refining the Who, When, and How of SGLT2-Inhibitors of Patients with HFpEF

This episode provides an in-depth analysis of the EMPEROR-Preserved study, including the main components of the study methodology, patient population, efficacy and safety findings, and overall clinical application. A review of SGLT2 inhibitors in HF is also covered, along with a discussion of ongoing studies.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.